Manulife Hong Kong launches critical illness plan with overseas treatment benefit

Danny Lee

Manulife Hong Kong has launched a specially designed critical illness plan called of Manulife Bright Care PRO, designed to allow customers access to overseas treatments.

The plan provides coverage for up to 123 critical illnesses and diseases up to the age of 100, along with extra financial support for overseas or non-conventional treatment for late-stage cancer.  The product was launched on 25 July.

Manulife Bright Care PRO offers a first-in-market late-stage cancer treatment benefit, providing additional financial support for overseas treatments that are not available locally or require long waiting times at home.  

Additionally, the plan supports off-label or clinical trial cancer drug treatments recommended by doctors when conventional treatment options do not work well or have intolerable side effects. 

The new benefit aims to provide a financial safety net for customers with late-stage cancer, who may need to access overseas treatments or off-label/clinical trial drugs, in order to pursue life-saving treatment options. 

Danny Lee, chief product officer (CPO), Manulife Hong Kong and Macau, said: “With surging medical costs and the financial burden posed by critical illnesses, it is crucial for people to have access to affordable and comprehensive protection for both themselves and their loved ones.

“According to the recent Manulife GBA Health Protection Survey, Hong Kong consumers face the burden of allocating a significant portion of their average monthly income to cancer treatment, revealing the pressing need for affordable yet comprehensive critical illness coverage.  

“Our new plan aims to fill this need by providing a range of features that offer customers the financial support they need to choose their most suitable cancer treatment and recovery options.” 

The plan caters to the diverse needs for critical illness coverage by introducing a first-in-market late stage cancer treatment benefit and coverage for attention deficit/hyperactivity disorder (ADHD), as well as protection against other juvenile diseases.  

To offer further protection against the most prevalent critical illnesses, the plan provides multiple coverage for cancer, heart attack (myocardial infarction) and stroke, all of which have a high recurrence risk.  

Additionally, it offers two tiers of protection for intensive care unit (ICU) stays, providing extended protection against non-designated critical illnesses and injuries, as well as the added benefits of a parental compassionate premium waiver and a level, guaranteed premium. 

 

 

Exit mobile version